Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B.
Kiyosawa
K
K
Tanaka
E
E
D000998:Antiviral Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial / Q000235:genetics; D006515:Hepatitis B virus / Q000187:drug effects* / Q000235:genetics*; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000494:pharmacology*; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*
D000998:Antiviral Agents; D018894:Reverse Transcriptase Inhibitors; D019259:Lamivudine